Oxford University's COVID-19 vaccineOfficially dubbed as AZD1222, the COVID-19 vaccine has been developed by the Jenner Institute, a part of the Nuffield Department of Medicine at the University of Oxford.
The formulation is backed by by AstraZeneca PLC, a British-Swedish pharmaceutical company. The vaccine has shown positive results in the initial trial.
The vaccine candidate is safe and prompts protective immune response, according to a report in The Lancet.AstraZeneca has joined Serum Institute of India (SII), the world's largest vaccine manufacturers by number of doses produced and sold, to produce the potential vaccine in India.